Logo

Biocius

Agilent Partners with Integrated Diagnostics, Further Signaling Focus on MRM-MS as Clinical Platform
Premium

By Adam Bonislawski Agilent Technologies and Integrated Diagnostics said this week that they have entered a strategic partnership to develop mass spec workflows for protein biomarker diagnostics.

Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
Premium

By Adam Bonislawski Proteomics in 2011 continued its long, hard slog toward the clinic, battling now-familiar challenges like sluggish test sales, unproven platforms, and the vagaries of the regulatory process.

Movers & Shakers: Jul 8, 2011
Premium

Albert Fornace, Amrita Cheema, Dilek Mir, Gregory Critchfield

Biocius Buy Key to Agilent's Clinical Proteomics Plans
Premium

While Biocius' RapidFire technology has traditionally been used by pharma firms for drug-screening work, "one of the key opportunities" Agilent sees is applying the platform "to the clinical proteomics space," a company official said.

Agilent Acquires Biocius, Lab901

"With this technology and the team that developed it now part of Agilent, we can expand our reach in the pharmaceutical and clinical mass spec markets," an Agilent official said of the Biocius purchase.